首页> 外文期刊>Cardiology in the young >Is Lipoprotein (a) A Risk Marker Of Coagulation Abnormalities In Patients With Single Ventricle Physiology?
【24h】

Is Lipoprotein (a) A Risk Marker Of Coagulation Abnormalities In Patients With Single Ventricle Physiology?

机译:脂蛋白(a)是单心室生理患者凝血功能异常的危险标志吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Concentration of Lipoprotein (a) [Lp (a)] is genetically determined and plays an important role in childhood thrombosis. Patients with single ventricle (SV) physiology suffer from recurrent thrombotic events. The relevant risk markers of thrombosis in this population are still missing. The aim of the study was to test the hypothesis, that increased Lp (a) levels are associated with hemocoagulation abnormalities in SV patients. Methods: After obtaining institutional ethical committee approval and informed parental consent, 60 patients with SV physiology admitted to Children's Cardiac Center in Slovakia between October 2005 and September 2007 were included into the study. Fifty healthy children were assessed as age-matched controls.
机译:背景:脂蛋白(a)[Lp(a)]的浓度由遗传决定,在儿童血栓形成中起重要作用。具有单心室(SV)生理功能的患者会反复出现血栓形成事件。该人群血栓形成的相关危险标志物仍然缺失。该研究的目的是检验这一假说,即Lp(a)水平升高与SV患者的凝血异常有关。方法:2005年10月至2007年9月在斯洛伐克儿童心脏中心收治的60例SV生理学患者,在获得机构伦理委员会的批准并获得父母的知情同意后,被纳入研究。将五十名健康儿童作为年龄匹配的对照。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号